These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 17888644

  • 1. Toll-like receptors: paving the path to T cell-driven autoimmunity?
    Marsland BJ, Kopf M.
    Curr Opin Immunol; 2007 Dec; 19(6):611-4. PubMed ID: 17888644
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.
    Ramanathan S, Gagnon J, Ilangumaran S.
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56(5):311-23. PubMed ID: 18836862
    [Abstract] [Full Text] [Related]

  • 8. The role of innate immune responses in autoimmune disease development.
    Waldner H.
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF, Miyahara Y, Wang HY.
    Oncogene; 2008 Jan 07; 27(2):181-9. PubMed ID: 18176599
    [Abstract] [Full Text] [Related]

  • 12. Multiple paths to loss of anergy and gain of autoimmunity.
    Conrad FJ, Rice JS, Cambier JC.
    Autoimmunity; 2007 Sep 07; 40(6):418-24. PubMed ID: 17729035
    [Abstract] [Full Text] [Related]

  • 13. Peripheral tolerance in CD8+ T cells.
    Srinivasan M, Frauwirth KA.
    Cytokine; 2009 May 07; 46(2):147-59. PubMed ID: 19268604
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Toll-like receptors in autoimmunity.
    Fischer M, Ehlers M.
    Ann N Y Acad Sci; 2008 Nov 07; 1143():21-34. PubMed ID: 19076342
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Insights into the role of Toll-like receptors in modulation of T cell responses.
    Kulkarni R, Behboudi S, Sharif S.
    Cell Tissue Res; 2011 Jan 07; 343(1):141-52. PubMed ID: 20680345
    [Abstract] [Full Text] [Related]

  • 18. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P, Guazzone VA, Jarazo-Dietrich S, Theas MS, Lustig L.
    J Reprod Immunol; 2009 Jul 07; 81(1):44-54. PubMed ID: 19520436
    [Abstract] [Full Text] [Related]

  • 19. Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer.
    Wang RF.
    Semin Cancer Biol; 2006 Feb 07; 16(1):73-9. PubMed ID: 16140545
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cells from bench to bedside and back.
    Adema GJ.
    Immunol Lett; 2009 Feb 21; 122(2):128-30. PubMed ID: 19121337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.